Title : Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.

Pub. Date : 2013 Oct

PMID : 24007746






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTERPRETATION: A short, four-cycle regimen of docetaxel and cyclophosphamide combined with trastuzumab could be an option for adjuvant treatment of women with lower risk HER2-amplified early breast cancer, irrespective of TOP2A status. Cyclophosphamide DNA topoisomerase II alpha Homo sapiens